中文名稱:3-羥基丁酸 | 英文名稱:3-Hydroxybutyric acid |
CAS:300-85-6 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.77% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T4947 |
名稱 | 3-Hydroxybutyric acid |
描述 | 3-Hydroxybutyric acid (Butanoic acid) (or beta-hydroxybutyrate) is a ketone body. Like the other ketone bodies (acetoacetate and acetone), levels of 3-hydroxybutyrate in blood and urine are raised in ketosis. In humans, 3-hydroxybutyrate is synthesized in the liver from acetyl-CoA and can be used as an energy source by the brain when blood glucose is low. Blood levels of 3-hydroxybutyric acid levels may be monitored in diabetic patients to look for diabetic ketoacidosis. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing mammals. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for the synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first 2 weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmitoylphosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391 ). 3-Hydroxybutyric acid is found to be associated with fumarase deficiency and medium-chain acyl-CoA dehydrogenase deficiency, which are inborn errors of metabolism. |
存儲(chǔ)條件 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | H2O : 200 mg/mL (1.92 M) DMSO : 55 mg/mL (528.34 mM) |
關(guān)鍵字 | inhibit | Endogenous Metabolite | Inhibitor | diabetes | β-Hydroxybutyric acid | 3Hydroxybutyric acid | membrane | metabolite | 3-Hydroxybutyric acid | lipids | 3 Hydroxybutyric acid | type |
相關(guān)產(chǎn)品 | Oleamide | p-Hydroxybenzaldehyde | Guanidine hydrochloride | Naringin | Daidzein | Glycerol | Sucrose | Oxalic acid dihydrate | Ferulic Acid | 3-Indoleacetic acid | Thymidine | Fumaric acid |
相關(guān)庫(kù) | 經(jīng)典已知活性庫(kù) | 已知活性化合物庫(kù) | 人內(nèi)源代謝化合物庫(kù) | 腸道微生物代謝化合物庫(kù) | 煙草單體化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.2651萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 化學(xué)試劑,生物活性小分子 | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥200 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-01-10 | |
¥420 |
VIP14年
|
湖南匯百侍生物科技有限公司
|
2024-12-12 | |
¥720.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 | |
詢價(jià) |
湖北新迪科化學(xué)有限公司
|
2024-07-24 |